Fairchem Organics Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Published 17 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹1.0K Cr

Current capacity is 80,000 tonnes with ~65-66% utilization; expected to reach over 95% utilization in next two years. - Addition of new 40,000 tonnes capacity in progress; novel product plant to be commissioned in Q2. - Revenue target of Rs. The company targets to improve EBIT margins to around 8% in the near term with volume growth, rupee devaluation, and energy-saving initiatives supporting margin expansion.

From Fairchem Organics Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Price

₹660

Market Cap

₹1.0K Cr

P/E Ratio

66.5

How does Fairchem Organics Ltd rank in Chemicals & Petrochemicals?

Compare Fairchem Organics Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Fairchem Organics Ltd — Quarterly revenue & net profit

Revenue Net Profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹117 Cr, net profit ₹4 Cr.

Full financials →

📊 Revenue & Sales Performance

→Current capacity is 80,000 tonnes with ~65-66% utilization; expected to reach over 95% utilization in next two years.
→Addition of new 40,000 tonnes capacity in progress; novel product plant to be commissioned in Q2.
→Revenue target of Rs. 800-1,000 crores from new capacity expected within five years.
→Long-term vision aims for Rs. 2,000 crores revenue by FY’30.
→Export contribution expected to grow from current 8-10% to about 20% by FY’27.
→Volume growth: FY’23 volume was 54,000 tonnes; FY’24 increased to 63,000 tonnes; FY’25 volume around 54,000 tonnes; FY’26 volume was 44,000 tonnes.
→Expect capacity utilization to reach 75-80% and 40,000 tonnes capacity to be fully utilized in five years.
→Margins and volume growth expected to improve with export tailwinds, rupee depreciation, and energy-saving initiatives.

📈 Profitability & Margins

→The company targets to improve EBIT margins to around 8% in the near term with volume growth, rupee devaluation, and energy-saving initiatives supporting margin expansion.
→Operating leverage expected as plant utilization increases from current ~65% to over 95% in the next two years, which will further boost margins.
→Margins could potentially reach double digits with sustained volume growth and cost efficiencies.
→New product launches (40,000 tonnes capacity addition) expected by FY’27-28, contributing to higher revenue (Rs. 800-1000 crores) with better margins (15-18%).
→Export share expected to grow from ~9% to 20% by FY’27, benefiting from favorable currency and reduced Chinese dumping.
→Long-term revenue target around Rs. 2000 crores in 5+ years driven by increased capacity and new product streams.
→Energy audit and cost optimization measures are ongoing, expected to improve operating profits over time.

See what Fairchem Organics Ltd said on profitability & margins — free account, 30 seconds.

🏗️ Capital Expenditure Plans

→No major CAPEX planned for FY2027 except for energy-saving initiatives based on audit results; investments will be made only if payback is less than four years.
→CAPEX for FY2028 depends on the uptake of a new product; if the product gains traction, investment will follow; current business does not require CAPEX.
→Recently incurred Rs. 20-25 crores CAPEX for the first phase of commissioning a new product plant with 40,000 tonnes capacity, phased as demand grows.
→Bypass fat plant to start operation next month, new specialty chemical product plant to start by end of Q2.
→Overall focus is on improving top-line growth rather than aggressive expansion at present.

💰 Fundraising & Capital Structure

- For FY27, there will not be any CAPEX except for energy-saving initiatives, which will be undertaken only if payback is less than four years. - For FY28, CAPEX plans depend on the uptake of the new product; if it picks up, investment will be considered, otherwise no CAPEX for the current business. - No mention of any new fundraising through debt or equity in the near term. - The company has avoided aggressive expansion and debt-taking during the past two challenging years. - Efforts to expand and invest will resume as market conditions stabilize but with no explicit mention of raising funds through debt or equity at this time. In summary, there are no current or planned fundraising initiatives through debt or equity disclosed in the provided information.

See what Fairchem Organics Ltd said on fundraising & capital structure — free account, 30 seconds.

📋 Order Book & Pipeline

The document does not explicitly mention the current or expected order book or pending orders for the company. However, relevant details related to demand and volumes are: - FY'23 peak volume was around 54,000 tonnes. - In FY'24, volume went up to 63,000 tonnes but revenue decreased due to price correction. - FY'25 volume fell to 44,000 tonnes. - New product capacity of 40,000 tonnes expected to be commissioned by Q2 (probably FY'27 or FY'28). - Capacity utilization expected to reach 75-80% in near term and possibly 95% in next two years. - Export contribution currently around 8-10%, expected to rise to 20% in FY'27. - Revenue target of Rs. 800-1,000 crores from new product capacity in five years. No specific figures on order book or pending orders were disclosed.

Key Metrics

What Fairchem Organic's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

NOCIL (Q4 FY26)
The Rs.130 crores capex includes some intermediates and is largely for captive consumption, with part allocated to finished goods. Key concall takeaways from…
Indo Borax & Chemicals Ltd (Q4 FY26)
175 crores revenue in the previous financial year and Rs. Key concall takeaways from Indo Borax & Chemicals Ltd's Q4 FY26 earnings call — and how it ranks…
Rossari Biotech (Q4 FY26)
50-70 crore planned for FY27 focused on pharma and aroma chemical facilities to support value-added product segments. Key concall takeaways from Rossari…
Pidilite Inds. (Q4 FY26)
Underlying volume growth (UVG) averaged over 9% per quarter last year, with a ~200 bps increase in FY '25; the company plans to continue lifting UVG…

Compare:vs Pidilite Inds.vs SRF vs Linde India Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Fairchem Organics Ltd Q4 FY26 results?

What is Fairchem Organics Ltd share price analysis?

Fairchem Organics Ltd currently shows a neutral. The stock trades at a P/E of 66.5 with a market cap of ₹1,005 Cr. Investors should review the full earnings analysis for detailed insights.

Is Fairchem Organics Ltd planning capital expenditure?

No major CAPEX planned for FY2027 except for energy-saving initiatives based on audit results; investments will be made only if payback is less than four years. - CAPEX for FY2028 depends on the uptake of a new product; if the product gains traction, investment will follow; current business does not require CAPEX. - Recently incurred Rs.

Keep Fairchem Organics Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.